✦ LIBER ✦

Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma

✍ Scribed by Hung Huynh; Richard Ong; Khee Chee Soo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

482 INK128, a potent and selective TORC1

✍ Y. Liu; K. Jessen; S. Wang; L. Kessler; L. Li; L. Darjania; M. Martin; P. Ren; P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 64 KB

874 ALK Inhibitors and Vaccination Again

✍ C. Voena; M. Menotti; C. Mastini; F. Di Giacomo; D. Longo; C. Martinengo; S. Aim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

151 Allosteric MEK inhibitor BAY 86-9766

✍ F. Puehler; A. Scholz; M. Kissel; A. Adjei; J.N. Miner; M. Hitchcock; R. Schmied 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

148 BAY 57-9352: an inhibitor of VEGFR-2

✍ Y. Chang; C. Cortes; C. Brink; B. Polony; P. Vincent; D. Xue; D. Wilkie; A. McNa 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

O10 CRM1-selective inhibitors of nuclear

✍ Festuccia, C.; Tortoreto, M.; Mancini, A.; Muzi, P.; Ventura, L.; Addis, A.; Lan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 182 KB

284 SYNERGISTIC ANTI-TUMOR EFFECT OF ACT

✍ W. Kim; D. Kim; Y.J. Jung 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 82 KB